CELC - Celcuity Inc. Annual Revenue Growth (Last Twelve Months)

The implementation of robotic sample analysis systems optimizes research, which correlates with the TTM annual revenue growth rate of Celcuity Inc. (CELC). The value 0.00 shows the current value of the metric. The business relies on identifying molecular defects for personalized treatment, while gedatolisib trials and the prospects of acquisition by major oncology centers drive the rise in share prices.
Summary analytical data breakdowns for Celcuity (CELC)

Celcuity Inc. specializes in developing innovative diagnostic systems for precision oncology therapy. The comparative year-over-year sales dynamics over a rolling period reflect the company's success in commercializing these technologies and the effectiveness of its partnerships with pharma behemoths. This metric is calculated as the percentage change in revenue over the last twelve months relative to the same period last year. Growth in this metric confirms real market demand, although it requires comparison with the debt load to assess capital sustainability.